Published in Pediatr Cardiol on July 05, 2011
Public health science agenda for congenital heart defects: report from a Centers for Disease Control and Prevention experts meeting. J Am Heart Assoc (2013) 1.07
Genetic basis of congenital cardiovascular malformations. Eur J Med Genet (2014) 1.00
Trends in survival among children with Down syndrome in 10 regions of the United States. Pediatrics (2012) 0.98
Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalities. Eur J Hum Genet (2012) 0.91
Duplication of the ALDH1A2 gene in association with pentalogy of Cantrell: a case report. J Med Case Rep (2013) 0.85
GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol (2012) 0.84
Genome-wide copy number variant analysis for congenital ventricular septal defects in Chinese Han population. BMC Med Genomics (2016) 0.81
Genetics and Genomics of Congenital Heart Disease. Circ Res (2017) 0.81
Brain Injury in Neonates with Complex Congenital Heart Disease: What Is the Predictive Value of MRI in the Fetal Period? AJNR Am J Neuroradiol (2016) 0.80
Cytogenomic Aberrations in Congenital Cardiovascular Malformations. Mol Syndromol (2016) 0.79
Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening. Semin Perinatol (2015) 0.78
Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal Defects. G3 (Bethesda) (2015) 0.78
A de novo duplication of chromosome 9q34.13-qter in a fetus with Tetralogy of Fallot Syndrome. Mol Cytogenet (2016) 0.77
Chromosomal abnormalities in patients with congenital heart disease. Arq Bras Cardiol (2013) 0.77
Congenital heart disease and chromossomopathies detected by the karyotype. Rev Paul Pediatr (2014) 0.76
Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defects. Genet Med (2014) 0.76
Tetralogy of Fallot and Hypoplastic Left Heart Syndrome - Complex Clinical Phenotypes Meet Complex Genetic Networks. Curr Genomics (2015) 0.76
Transition from paediatric to adult care of adolescent patients with congenital heart disease: a pathway to optimal care. Neth Heart J (2016) 0.75
Current Practice and Utility of Chromosome Microarray Analysis in Infants Undergoing Cardiac Surgery. Congenit Heart Dis (2014) 0.75
Population attributable danger of hereditary heart breaks. Risk factors among newborns in Yazd, Iran. J Med Life (2015) 0.75
Chromosome microarray analysis in the investigation of children with congenital heart disease. BMC Pediatr (2017) 0.75
Conditional Creation and Rescue of Nipbl-Deficiency in Mice Reveals Multiple Determinants of Risk for Congenital Heart Defects. PLoS Biol (2016) 0.75
Editorial brain malformation surveillance in the Zika era. Birth Defects Res A Clin Mol Teratol (2016) 0.75
Rare copy number variants in patients with congenital conotruncal heart defects. Birth Defects Res (2017) 0.75
Genetic Testing Protocol Reduces Costs and Increases Rate of Genetic Diagnosis in Infants with Congenital Heart Disease. Pediatr Cardiol (2017) 0.75
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 13.70
Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87
Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab (2006) 3.67
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003. MMWR Morb Mortal Wkly Rep (2007) 3.02
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr (1989) 2.55
Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep (2008) 2.52
Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr (2006) 2.41
Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med (2008) 2.23
Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics (2008) 2.00
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
Estimates of the economic costs of birth defects. Inquiry (1994) 1.82
The incidence of congenital heart defects in the first year of life. J Paediatr Child Health (1993) 1.63
Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet (1998) 1.56
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med (2008) 1.36
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet (2009) 1.34
Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol (2009) 1.33
Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol (2001) 1.04
Syndromes and malformations associated with congenital heart disease in a population-based study. Int J Cardiol (1999) 1.04
Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Epidemiology of major congenital heart defects in Sweden, 1981-1986. J Epidemiol Community Health (1992) 1.02
Double outlet right ventricle: aetiologies and associations. J Med Genet (2008) 1.01
Descriptive epidemiology of congenital heart disease in Northern England. Paediatr Perinat Epidemiol (2009) 1.00
Chromosome abnormalities in congenital heart disease. Am J Med Genet (1997) 0.98
New trends in chromosomal investigation in children with cardiovascular malformations. Cardiol Young (2004) 0.96
Risk factors in congenital heart disease. Eur J Epidemiol (1989) 0.93
Associations between chromosomal anomalies and congenital heart defects: a database search. Am J Med Genet (1999) 0.93
The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations. Pediatr Cardiol (2003) 0.90
Temporal variability in birth prevalence of congenital heart defects as recorded by a general birth defects registry. J Pediatr (2003) 0.86
Congenital cardiovascular malformations (CCVM) and structural chromosome abnormalities: a report of 9 cases and literature review. Clin Genet (1990) 0.80
Unexpected survival in a case of prenatally diagnosed non-mosaic trisomy 22: Clinical report and review of the natural history. Am J Med Genet A (2003) 0.76
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet (2008) 7.13
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr (2008) 3.87
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med (2011) 3.51
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet (2010) 2.70
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res (2004) 2.49
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation (2010) 2.26
Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med (2008) 2.23
Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health (2009) 2.09
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92
Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol (2011) 1.89
Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab (2010) 1.76
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68
Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol (2005) 1.68
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics (2009) 1.66
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect (2004) 1.61
Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet (2003) 1.61
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Ambient air pollution and preterm birth: a time-series analysis. Epidemiology (2009) 1.57
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol (2009) 1.54
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Quantifying geocode location error using GIS methods. Environ Health (2007) 1.48
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Temporal trends in survival among infants with critical congenital heart defects. Pediatrics (2013) 1.45
Segmental duplications mediate novel, clinically relevant chromosome rearrangements. Hum Mol Genet (2009) 1.44
Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics (2010) 1.43
Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care (2012) 1.43
Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet (2010) 1.43
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
FRIL: A tool for comparative record linkage. AMIA Annu Symp Proc (2008) 1.38
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. Birth Defects Res A Clin Mol Teratol (2006) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
The chromosomal polymorphism linked to variation in social behavior in the white-throated sparrow (Zonotrichia albicollis) is a complex rearrangement and suppressor of recombination. Genetics (2008) 1.32
Improving the quality of surveillance data on congenital heart defects in the metropolitan Atlanta congenital defects program. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
Seasonality of birth and implications for temporal studies of preterm birth. Epidemiology (2009) 1.28
Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics (2011) 1.28
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr (2008) 1.23
Residential mobility during pregnancy: patterns and correlates. Matern Child Health J (2009) 1.23
Cardiomyopathy and carnitine deficiency. Mol Genet Metab (2008) 1.22
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21